Androgenic Alopecia is one of the most common reasons for hereditary baldness. Most of the young generation is facing early hair loss. Minoxidil is the only FDA-approved drug used to treat the early stages of hair loss. Minoxidil is the most effective drug that can be used orally or through topical application. But there is variability in drug response. Only 50% of men and 40% of women will respond to minoxidil for hair loss treatment.
Why only a few are responding to minoxidil? Because minoxidil is a prodrug and needs to be activated. Minoxidil will be converted into minoxidil sulfate by sulfotransferase enzyme. We can call it SULT1A1 enzyme. The sulphotransferase enzyme present in the outer sheet of hair follicles will convert minoxidil into its active form minoxidil sulfate to perform its action. People with less sulphotransferase enzyme cannot convert minoxidil into minoxidil sulfate. So, people with low sulphotransferase will not respond to minoxidil treatment.
TrichoGene – A Hyderabad-based start-up founded by Dr.M. Sai Babu and Mohd. Rizwan Younus is providing an important testing service that tells about minoxidil response. TrichoGene-MRT (Minoxidil Response Test) provides valuable information to doctors about minoxidil response. MRT reports will be useful for providing precision treatment for Androgenic Alopecia / pattern baldness. MRT can be done with blood or buccal swab sample. What you need to do is just login to www.trichogene.in and order MRT. Kit will reach your doorstep through speed courier. Once you receive the kit, the buccal swab sample will be collected by following instructions given in the kit insert. Collect sample and send back to lab. Your report will be ready in 7 working days. Based on the MRT report, the doctor will suggest more precise hair loss treatment.
We made Minoxidil Response Test affordable to everyone. All minoxidil users should test before using minoxidil which saves time and money – said founders of TrichoGene.